Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 4.13M | $52.0M | 17.39% | +1.88M | 2026-06-30 |
| Boxer Capital Management, LLC | 3.15M | $40.0M | 13.27% | -- | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 2.72M | $34.0M | 11.45% | +625.0K | 2026-06-30 |
| Bvf Inc | 2.35M | $29.0M | 9.90% | -- | 2026-06-30 |
| RA Capital Management, L.P. | 2.33M | $29.0M | 9.83% | -- | 2026-06-30 |
| Point72 Asset Management, L.P. | 1.17M | $14.0M | 4.94% | -- | 2026-06-30 |
| Opaleye Management Inc. | 931.0K | $11.0M | 3.92% | -325.2K | 2026-06-30 |
| Logos Global Management LP | 800.0K | $10.0M | 3.37% | -- | 2026-06-30 |
| SummitTX Capital, L.P. | 733.8K | $9.0M | 3.09% | -- | 2026-06-30 |
| Ikarian Capital, LLC | 630.0K | $8.0M | 2.65% | -- | 2026-06-30 |
